NCT00003663View on ClinicalTrials.gov

Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 1998

Primary Completion Date

January 31, 2000

Study Completion Date

January 31, 2000

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

DRUG

dexamethasone

Trial Locations (3)

47403

Cancer Care Center for Southern Indiana, Bloomington

77802

St. Joseph Regional Cancer Center, Bryan

92658

Hoag Memorial Hospital Presbyterian, Newport Beach

Sponsors
All Listed Sponsors
collaborator

Cancer Biotherapy Research Group

OTHER

lead

Hoag Memorial Hospital Presbyterian

OTHER

NCT00003663 - Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter